prognosis Flashcards

1
Q

agranulocytosis

A

Overwhelming infections can cause death within hours to days.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

neutropenia

A

-Increased susceptibility to bacterial and fungal infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hemophagocytic Lymphohistocytosis (HLH)

A

Treated: 50% survive
—May have significant sequelae (renal damage: adults, mental retardation: children).

Untreated: grim prognosis, < 2 months survival if familial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ALL (acute lymphoblastic leukemia)

A

o Poor Prognosis if
“ Age < 2 (MLL translocation).
“ T(9:22) Philadelphia ch.
“ Presentation in adolescence or adulthood.
“ Peripheral blood blast count > 100,000 (high tumor burden likely).
“ Detection of residual disease after therapy.

o	Favorable Prognosis if:
"	Age between 2 and 10 yo.
"	Low white cell count.
"	Hyperdiploidy.** 90% have this
"	Chromosome 4, 7, 10 trisomy.
"	Presence of t(12:21).
  • leading cause of childhood death d/t cancer.
  • 95% of children reach complete remission.

adults: Only 35-45% are cured d/t different molecular pathogenesis and inability to tolerate the necessary chemo regimen effective in children

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Richter synd (from C/SLL (chronics,small lymphocytic leukemia))

A

under 1yr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

C/SLL (chronics,small lymphocytic leukemia)

A

Median survival 4-6 yrs, 10 yrs in pts with Decreased tumor burden at diagnosis.

Poor Prognosis if:

  • 11q, 17p deletions.
  • Lack of somatic hypermutation.
  • ZAP70 (+): augments Ig receptor signaling.
  • NOTCH1 mutations.
  • Richter syndrome.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

burkitt lymphoma

A
  • Responds well to chemotherapy.
  • Children and young adults are usually cured.
  • Older adults have more guarded outcome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

follicular lymphoma

A
  • waxing and waning course
  • 7-9 yrs regardless tx
  • progress DLBCL or burkitts –> 1 yr
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

DLBCL (diffuse large B cell lymphoma)

A
  • rapidly fatal w/o tx

- Treated: 60-80% complete remission, 40-50% cured.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

multiple myeloma (plasma cell myeloma)

A

Survival 4-7 yrs

If untx bone lesions: 6-12 mos

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

solitary myeloma (plasmocytoma)

A

Bone lesion in same locations as MM → multiple myeloma in 10-20 yrs even if it is resected.

Extraosseous lesions in lungs, oronasopharynx or nasal sinuses → cured by local resection. (not onto MM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

smoldering myeloma

A

75% progress (unpredictably) to multiple myeloma in 15 yrs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

-lymphoplasmacytic lymphoma

A

4 yrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

mantle cell lymphoma (MCL)

A

poor: 304 yrs

organ dysfunction d/t lack of effective chemo and tumor infiltration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

hairy cell leukemia

A

excellent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Peripheral T-cell Lymphoma, Unspecified

A

cure rare; worse prognosis than aggressive B cells

17
Q

Anaplastic Large Cell Lymphoma

A

good prog: kid and alk

bad prod: adult and alk-

18
Q

Adult T-cell Leukemia/Lymphoma

A
  • Rapidly progressive disease, fatal in months to 1 yr despite aggressive chemo.
  • If only skin is involved (rare), disease has a more indolent course
19
Q

Mycosis Fungoides & Sezary Syndrome

A

8-9 yrs

20
Q

Extranodal NK/T-cell Lymphoma

A

highly aggressive; poor in adv dis

21
Q

Hodgkin Lymphoma: Nodular Sclerosis Subtype
Hodgkin Lymphoma: Mixed Cellularity Subtype
Hodgkin Lymphoma: Lymphocyte Rich Subtype
Hodgkin Lymphoma: Lymphocyte Depletion Subtype
Hodgkin Lymphoma: Lymphocyte predominant Subtype

A
  • excellent: stage 1, 2
  • adv stage, but good prog
  • very good-excellent
  • adv stage, bad prog
  • excellent: stage 1, 2, but recur
22
Q
AML w genetic abbr
AML w MDS-like features
AML therapy related
AML, NOS
Overall:
A
  • AML w genetic abbr: favorable
  • AML w MDS-like features: poor
  • AML therapy related: very poor
  • AML, NOS: intermediate
  • overall: 60% remission with chemo, 5 yrs: 70-85% relapse.
23
Q

Myelodysplastic syndromes (MDS)

A
  • 9-29 survive

- Worse outcomes: higher blast counts, more severe cytopenias with multiple clonal chromo Abn

24
Q

t-MDS

A

4.8 mos, high progression to AML

25
Q

Chronic Myelogenous Leukemia (CML)

A
  • worse if not have phl chromo, in blast crisis, accelerated phase
  • w/o tx: 3 yrs
26
Q

Polycythemia Vera (PCV or PV)

A

untx: death w/in mos

27
Q

Essential Thrombocytosis (ET)

A

12-15 yr survival

28
Q

-Multifocal Multisystem Langerhans Cell Histiocytosis (letterer-siwe Disease)

A

Untreated = rapidly fatal

5 yr survival: 50%